Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis
Status:
Completed
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the macular and choroidal thickness of patients
submitted to intracameral moxifloxacin during the phacoemulsification surgery for
endophthalmitis prophylaxis.
The investigators propose a randomized clinical trial double-blind. The patients will be
divided into two groups: one will receive intracameral moxifloxacin injection during
phacoemulsification surgery and the other won't.
Both Spectral Domain - Optical Coherence Tomography (SD-OCT) and Enhanced Depth Imaging -
Optical Coherence Tomography (EDI-OCT) will be performed for each patient pre-operatively and
on the 30th and 60th postoperative days.
After collecting, the data will be compared to evaluate if there was any difference in the
macular thickness and choroidal thickness between the two groups.